Charles Winter
Hoofd Techniek/Wetenschap/O&O bij JANUX THERAPEUTICS, INC.
Vermogen: 3 M $ op 31-05-2024
Actieve functies van Charles Winter
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| JANUX THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 | - |
Loopbaan van Charles Winter
Eerdere bekende functies van Charles Winter
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ANAPTYSBIO, INC. | Corporate Officer/Principal | 01-08-2020 | 01-03-2021 |
| SYNTHORX, INC. | Corporate Officer/Principal | 01-01-2020 | 01-08-2020 |
| DENALI THERAPEUTICS INC. | Corporate Officer/Principal | 01-11-2016 | 01-06-2018 |
| JHL BIOTECH, INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2015 | 01-08-2016 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-09-2011 | 01-06-2015 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01-01-1994 | 01-09-2011 |
Opleiding van Charles Winter
| University of Wisconsin | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 8 |
| Kaaimaneilanden | 2 |
Operationeel
| Corporate Officer/Principal | 5 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 8 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| JANUX THERAPEUTICS, INC. | Health Technology |
| ANAPTYSBIO, INC. | Health Technology |
| DENALI THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
Synthorx, Inc.
 Synthorx, Inc. BiotechnologyHealth Technology Synthorx, Inc. focuses on prolonging and improving lives of cancer and autoimmune disorder patients. Its product pipeline is comprised of THOR-707, IL-2 Synthorin, IL-10 Synthorin, and IL-15 Synthorin. The company was founded by Floyd E. Romesberg and Court R. Turner in 2014 and is headquartered in La Jolla, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Beurs
- Insiders
- Charles Winter
- Ervaring
